---
layout: post
title: "Enforcement Policy for Non-Invasive Remote Monitoring Devices Used To Support Patient Monitoring; Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 18:57:16 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-23110
original_published: 2023-10-19 00:00:00 +0000
significance: 8.00
---

# Enforcement Policy for Non-Invasive Remote Monitoring Devices Used To Support Patient Monitoring; Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** October 19, 2023 00:00 UTC
**Document Number:** 2023-23110

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring." The enforcement policy described in this guidance applies to modified devices where the original device was a legally marketed, non-invasive remote monitoring device listed in the guidance that measures or detects common physiological parameters and that is used to support patient monitoring. The guidance is intended to describe the enforcement policy for limited modifications to the indications, functionality, or hardware or software of device types in the scope of the guidance without prior submission of a 510(k) where such submission would be required.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/10/19/2023-23110/enforcement-policy-for-non-invasive-remote-monitoring-devices-used-to-support-patient-monitoring)
- API: https://www.federalregister.gov/api/v1/documents/2023-23110

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
